OpenAI and Anthropic Safety Warnings Put Them at Odds With Trump Administration
The two largest U.S. AI developers are signaling calls to slow AI deployment, a position that puts them in direct tension with the current federal posture favoring rapid AI expansion and deregulation.
OpenAI and Anthropic PBC are prepared to publicly advocate for slowing the pace of artificial intelligence development on safety grounds, according to a September 14, 2026 report by Bloomberg. That position places both companies in conflict with the Trump administration, financial markets, and significant portions of the broader technology industry, all of which have pushed for accelerated AI deployment.
The Trump administration has pursued a deregulatory approach to artificial intelligence since taking office, positioning the United States in direct competition with China on AI capability development. That posture is reflected in statements by senior officials and in the administration's resistance to binding federal AI safety frameworks.
Speaker Mike Johnson stated publicly in 2026 that he opposes any federal moratorium on AI development, citing competitive pressure from China as the primary rationale, according to prior Congressional Times reporting. Johnson's position aligns with the administration's broader stance and reflects a significant faction within Congress that views regulatory restraint as strategically necessary.
AnthropicPBC is a private company incorporated as a public benefit corporation. OpenAI operates as a capped-profit entity. Both companies have received substantial private investment from Wall Street and technology sector backers who have a direct financial interest in continued rapid development and deployment of AI products.
The tension Bloomberg identified on September 14, 2026, is structural: both companies have internal safety teams and leadership that have warned publicly about risks associated with advanced AI systems, while their investors and the current federal government have financial and geopolitical incentives to minimize friction on deployment timelines.
At the federal level, no binding AI safety legislation has passed either chamber of Congress as of September 14, 2026. Multiple bills have been introduced in the Senate and House proposing various oversight frameworks, but none have cleared committee votes in the current session. The specific legislative vehicles, bill numbers, and committee referrals are a matter of congressional record available through Congress.gov.
The Commerce Department, through the National Institute of Standards and Technology, published a voluntary AI Risk Management Framework in January 2023. That framework carries no enforcement mechanism and participation by companies is not mandatory, according to NIST public documentation. Whether the current administration has directed NIST to update or revise that framework is not confirmed in publicly available agency records as of this publication date.
Wall Street's stake in the outcome is direct. Publicly traded companies with significant AI investment positions include Microsoft, Google parent Alphabet, and Amazon, all of which have disclosed AI-related capital expenditures in filings with the Securities and Exchange Commission. Any federal action to slow AI development could affect the valuation of those positions. The specific dollar amounts at risk would be contained in each company's most recent 10-Q and 10-K filings with the SEC.
AnthropicPBC and OpenAI have also each engaged in federal lobbying activity. Lobbying Disclosure Act filings available through the Senate Office of Public Records show both companies have registered lobbyists active on AI-related policy issues, though the specific dollar amounts, lobbying targets, and issue areas for the most recent reporting period are contained in their most recently filed LD-2 quarterly disclosures and should be reviewed directly in that database for precision.
What remains unknown as of September 14, 2026, is the specific policy action, if any, that OpenAI and Anthropic intend to take. It is also unknown whether either company plans to submit formal comments to a federal rulemaking proceeding, testify before Congress, or pursue another avenue of advocacy. The nature and timing of any such action would be reflected in congressional hearing records, Federal Register notices, or updated LDA filings, depending on the vehicle chosen.